Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze CORT stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate CORT investment potential.

What is CORT stock price today?

Get real-time CORT stock price, historical data, and price charts on Financhill. Track CORT performance with our advanced analysis tools.

Is CORT a good investment?

Evaluate CORT investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy CORT stock?

To buy CORT stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of CORT?

View detailed market capitalization data and company valuation metrics for CORT on our comprehensive analysis page.

What is the P/E ratio of CORT?

Use our fundamental analysis tools to view CORT P/E ratio and compare valuation metrics with industry peers.

What are CORT earnings?

View CORT earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Corcept Therapeutics, Inc. Stock Predictions

Exxon and Chevron Have an Unlikely New Competitor

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at

Sell

CORT
Corcept Therapeutics, Inc.

Last Price:

$37.47

Seasonality Move:

13.75%

7 Day Trial

ALL ACCESS PASS

$ 7

The Next Gold Rush

Corcept Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Corcept Therapeutics, Inc. has on average historically risen by 26.9% based on the past 21 years of stock performance.
Corcept Therapeutics, Inc. has risen higher in 11 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.38%
Is Corcept Therapeutics, Inc. Stock Undervalued?

The current Corcept Therapeutics, Inc. [CORT] share price is $37.50. The Score for CORT is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
CORT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Corcept Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Corcept Therapeutics, Inc. has on average historically risen by 26.9% based on the past 21 years of stock performance.

Corcept Therapeutics, Inc. Stock Rating

Sell

Corcept Therapeutics, Inc. (CORT) is a Sell

Is Corcept Therapeutics, Inc. overpriced?

Corcept Therapeutics, Inc. has risen higher in 11 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.38%

Corcept Therapeutics, Inc. Stock Price History

Is CORT stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CORT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

corcept.com

52-Week Data

52-Week High:

117.33

52-Week Low:

32.99

Prediction Charts

Market Cap:

3.9B

Price in USD:

37.50

Volume:

1.6M

Beta:

0.78

Technical Analysis

SMA50:

73.91

SMA100:

75.10

SMA200:

73.38

52-Wk Change:

-27.45%

Stock Predictions

Is Corcept Therapeutics, Inc. stock public?

Yes, Corcept Therapeutics, Inc. is a publicly traded company.
What is the Corcept Therapeutics, Inc. stock quote today?

The Corcept Therapeutics, Inc. stock price is 37.50 USD today.
How to buy Corcept Therapeutics, Inc. stock online?

You can buy Corcept Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-18	82.28	81.54	83.37	81.01
Dec-19	82.00	83.76	85.34	81.26
Dec-22	84.37	85.11	85.28	83.05
Dec-23	84.40	81.99	85.16	80.38
Dec-24	82.01	83.59	84.48	81.97
Dec-26	83.41	82.65	83.70	82.13
Dec-29	82.32	79.82	82.98	79.67
Dec-30	79.75	70.20	79.75	69.91
Dec-31	38.89	34.80	39.00	32.99
Jan-5	38.14	34.95	38.17	34.89
Jan-6	34.84	35.78	36.90	34.28
Jan-7	36.30	37.00	37.65	35.60
Jan-8	36.50	36.53	37.50	36.13
Jan-9	36.95	37.50	37.70	36.20

Corcept Therapeutics, Inc. Earnings

Corcept Therapeutics, Inc. Earnings Report: Per Share Corcept Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Corcept Therapeutics, Inc. Forecast Revenue Growth

Corcept Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Corcept Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and an increase next year of $2.18 per share.

* Corcept Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.